ReviewJournal of gastrointestinal cancer2026
Beyond Sidedness: DNA Methylation as a Biomarker to Refine Anti-EGFR Treatment Selection in RAS/BRAF Wild-type Metastatic Colorectal Cancer.
Tamotsu Sagawa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.